Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lilia González Cerón

Lilia González Cerón

Lilia González Cerón

Researcher at Regional Research Centre on Public Health of the National Institute of Public Health, Mexico, Researcher in Medical Sciences "E", CONACyT SNI I

Dr González Cerón, bachelors in Microbiology,  National School of Biological Sciences of the National Polithecnics Institute, ENCB- IPN (1986), MSc in Medical Parasitology by University of London (1991) and PhD by Centre of Research and Advance Studies, IPN (1998) in Mexico D.F.. Scholarships of the programme TDR-OMS/Geneva.

Researcher at Regional Research Centre on Public Health of the National Institute of Public Health (Centro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, CRISP-INSP), Researcher in Medical Sciences level "E"; since 1992 she has been a member of the SNI-CONACyT, Mexico, currently level I.

Dr González Cerón is the author of 41 publications, of which 34 are refereed specialised journal articles, four book chapters and three outreach articles. She has taught since 1993 and has participated in round-tables, symposiums, presented papers at 89 conferences and has been the guest speaker to six conferences. She has also supervised 12 undergraduate theses, nine masters’ theses and one PhD thesis.

Her research interest comprises the molecular parasitology of vector borne diseases with an emphasis in malaria: includes diagnostics and treatment, and the mechanisms of the parasite - hosts interaction. More recently, the research has been extended to the study of genetic diversity of Plasmodium vivax antigens.

Selected Publications:

Gonzalez-Ceron L, Rodriguez MH, Sandoval MA, Santillan F, Galindo-Virgen S, Betanzos AF, Rosales AF, Palomeque OL. “Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.” Malar J. 2015 Oct 30; 14(1):426. doi: 10.1186/s12936-015-0938-2.

Lilia Gonzalez-Ceron, Jesus Martinez-Barnetche, Ciro Montero-Solís, Frida Santillan, Aida M Soto, Mario H Rodriguez, Benjamin J Espinosa and Octavio A Chavez. “Molecular epidemiology of Plasmodium vivax in Latin America: polymorphism and evolutionary relationships of the circumsporozoite gene.” Malaria J 2013; 12:243. doi: 10.1186/1475-2875-12-243.

Gonzalez-Ceron L, Mu J, Santillán F, Joy D, Sandoval MA, Camas G, Su X, Choy EV, Torreblanca R. “Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico.” Parasite & Vectors. 2013 Apr 18; 6:109.